Fundz

First Ascent Biomedical raised $6M in an angel investment led by Vidal Duart Enterprises, Inc. to revolutionize cancer treatment with personalized technology.

PRIVATEJan 13, 2025

Amount Raised

$6 Million

Round Type

Angel

MiamiBiotechnologyHealth CareMedicalTherapeutics

Investors

Vidal Duart EnterprisesVidal Duart Enterprises, Inc.Techstars

Description

First Ascent Biomedical has secured a $6 million investment from Vidal Duart Enterprises, Inc., along with co-investment from Techstars. The funding will be used to enhance operations and establish a state-of-the-art lab in Florida, focusing on personalized cancer treatment technologies.

Company Information

Company

First Ascent Biomedical

Location

Miami, Florida, United States

About

First Ascent Biomedical is a leader in Functional Precision Medicine, leveraging advanced technologies to personalize cancer treatment. The company focuses on personalized cancer care with their innovative platform that integrates drug testing, DNA/RNA sequencing, and AI-guided tumor weakness mapping. Their technology aims to improve patient survival by moving away from one-size-fits-all approaches and providing tailored treatment strategies. They are committed to making cancer care widely accessible, especially for underserved communities.

Fundz sees it the moment First Ascent Biomedical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for First Ascent Biomedical's next move

See what Strategic adds

First Ascent Biomedical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.